BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/9/2021 10:25:22 AM | Browse: 474 | Download: 909
 |
Received |
|
2021-02-03 03:11 |
 |
Peer-Review Started |
|
2021-02-03 03:15 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-03-30 02:39 |
 |
Revised |
|
2021-04-08 03:30 |
 |
Second Decision |
|
2021-07-14 03:33 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-07-14 07:38 |
 |
Articles in Press |
|
2021-07-14 07:38 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-07-26 07:25 |
 |
Typeset the Manuscript |
|
2021-08-04 06:26 |
 |
Publish the Manuscript Online |
|
2021-08-09 10:25 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Dermatology |
Manuscript Type |
Editorial |
Article Title |
Clinical effects of antidiabetic drugs on psoriasis: The perspective of evidence-based medicine
|
Manuscript Source |
Invited Manuscript |
All Author List |
Mei-Xian Zhang, Bo-Yuan Zheng, Hai-Xiao Chen and Ching-Wen Chien |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Ching-Wen Chien, PhD, Professor, Institute for Hospital Management, Tsing Hua University, Shenzhen Campus, No. 2279 Lishui Street, Shenzhen 518055, Guangdong Province, China. ihhca@sz.tsinghua.edu.tw |
Key Words |
Psoriasis; Hypoglycemic agents; Thiazolidinediones; Glucagon-like peptide-1 receptor agonists; Dipeptidyl peptidase-4 inhibitors; Biguanides; Antipsoriatic effect; Evidence-based medicine |
Core Tip |
Several hypoglycemic agents including thiazolidinediones, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, and biguanides have been reported to make a remarkable reduction in the Psoriasis Area and Severity Index score from baseline. The antipsoriatic effect could be mediated not only by the glucose-lowering action of these agents but also via inhibition of keratinocyte overproliferation, increase expression of differentiation markers, suppression the immune inflammatory pathway, and blocking the calcium channels and mitogen-activated protein kinase signaling pathways. Potential bias in the study and missing data could undermine the reliability of the results. Therefore, the appropriately randomized controlled studies with large sample sizes and long-term durations in various psoriasis patients are warranted for further support. |
Publish Date |
2021-08-09 10:25 |
Citation |
Zhang MX, Zheng BY, Chen HX, Chien CW. Clinical effects of antidiabetic drugs on psoriasis: The perspective of evidence-based medicine. World J Diabetes 2021; 12(8): 1141-1145 |
URL |
https://www.wjgnet.com/1948-9358/full/v12/i8/1141.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v12.i8.1141 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345